Clinical Trial Update: Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates gemcitabine and carboplatin followed by laboratory-treated T lymphocytes (TIL therapy) in patients with metastatic or locally recur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• TIL therapy (tumor-infiltrating lymphocytes) (tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN